Financing Cash Flow
Idexx Laboratories Financing Cash Flow increased by 40.6% to -$211.43M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 36.0%, from -$330.32M to -$211.43M. Over 4 years (FY 2021 to FY 2025), Financing Cash Flow shows a downward trend with a 13.7% CAGR.
Analysis
How to read this metric
A large negative value typically indicates a company is returning capital to shareholders or paying down debt, while a positive value suggests the company is raising external capital to fund operations or acquisitions.
Detailed definition
This metric represents the net flow of cash between a company and its capital providers, including shareholders and lend...
Peer comparison
Large-cap peers like Microsoft or Alphabet similarly show large negative financing outflows due to aggressive share repurchase programs and dividend distributions.
net_cash_from_financingHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$180.22M | -$221.73M | -$165.82M | -$13.48M | -$91.91M | -$148.83M | -$116.72M | -$146.08M | -$151.03M | -$43.04M | -$101.84M | -$144.07M | -$210.24M | -$290.98M | -$232.78M | -$330.32M | -$165.63M | -$313.31M | -$355.70M | -$211.43M |
| QoQ Change | — | -23.0% | +25.2% | +91.9% | -581.8% | -61.9% | +21.6% | -25.2% | -3.4% | +71.5% | -136.6% | -41.5% | -45.9% | -38.4% | +20.0% | -41.9% | +49.9% | -89.2% | -13.5% | +40.6% |
| YoY Change | — | — | — | — | +49.0% | +32.9% | +29.6% | -983.7% | -64.3% | +71.1% | +12.7% | +1.4% | -39.2% | -576.1% | -128.6% | -129.3% | +21.2% | -7.7% | -52.8% | +36.0% |
Financing Cash Flow at Other Companies
Frequently Asked Questions
- What is Idexx Laboratories's financing cash flow?
- Idexx Laboratories (IDXX) reported financing cash flow of -$211.43M in Q1 2026.
- How has Idexx Laboratories's financing cash flow changed year-over-year?
- Idexx Laboratories's financing cash flow increased by 36.0% year-over-year, from -$330.32M to -$211.43M.
- What is the long-term trend for Idexx Laboratories's financing cash flow?
- Over 4 years (2021 to 2025), Idexx Laboratories's financing cash flow has grown at a 13.7% compound annual growth rate (CAGR), from -$697.41M to -$1.16B.
- What does financing cash flow mean?
- The total amount of money a company spends or receives from borrowing debt and managing its own shares and dividends.